Monopar Therapeutics (MNPR)

CIK 1645469 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Monopar Therapeutics.

Recent SEC filings

FiledFormAccession number
Aug 28, 20264/A0001437749-26-029235
Aug 28, 20264/A0001437749-26-029228
Aug 27, 202640001437749-26-029115
Aug 27, 202640001437749-26-029121
Aug 27, 202640001437749-26-029116
Aug 26, 20261440001950047-26-008724
Aug 26, 20261440001950047-26-008721
Aug 25, 20261440001950047-26-008691
Aug 12, 202610-Q0001437749-26-027164
Aug 12, 20268-K0001437749-26-027165
Aug 12, 2026SCHEDULE 13G/A0002060757-26-000047
Aug 12, 2026SCHEDULE 13G/A0000919574-26-004969
Jul 22, 20268-K0001437749-26-024041
Jul 22, 2026S-8 POS0001437749-26-024130
Jul 22, 2026S-80001437749-26-024127
Jul 22, 2026S-8 POS0001437749-26-024131
Jul 22, 2026S-8 POS0001437749-26-024129
Jul 22, 2026S-8 POS0001437749-26-024132
Jul 10, 2026144/A0001628280-26-047932
Jul 7, 20261440001628280-26-047461
Jul 2, 202640001437749-26-022630
Jul 2, 202640001437749-26-022628
Jul 2, 202640001437749-26-022631
Jun 30, 202640001437749-26-022164
Jun 30, 20268-K0001437749-26-022086